Literature DB >> 17072584

The atypical antipsychotic clozapine impairs insulin secretion by inhibiting glucose metabolism and distal steps in rat pancreatic islets.

N Sasaki1, M Iwase, Y Uchizono, U Nakamura, H Imoto, S Abe, M Iida.   

Abstract

AIMS/HYPOTHESIS: Diabetogenic effects of some atypical antipsychotic drugs have been reported, although the mechanisms are not fully understood. We investigated the long-term effects of culturing isolated rat pancreatic islets with atypical antipsychotic clozapine.
METHODS: Glucose- and non-glucose-stimulated insulin secretion, glucose metabolism and intracellular Ca(2+) concentration ([Ca(2+)](i)) were measured in islets cultured with or without clozapine.
RESULTS: Although acute incubation or 3-day culture with clozapine did not affect glucose-stimulated insulin secretion, clozapine suppressed glucose-stimulated insulin secretion by 53.2% at 1.0 micromol/l (therapeutic concentration) after 7 days of culture. Islet glucose oxidation and [Ca(2+)](i) elevation by high glucose were not affected after 3 days of culture, but clozapine significantly inhibited islet glucose oxidation, ATP production, and [Ca(2+)](i) elevation by high glucose after 7 days of culture. Moreover, 7 days of culture with clozapine inhibited insulin secretion stimulated by: (1) membrane depolarisation induced by high K(+); (2) protein kinase C activation; and (3) mastoparan at 16.7 mmol/l glucose under stringent Ca(2+)-free conditions. Elevation of [Ca(2+)](i) by high K(+)-induced membrane depolarisation was similar in control and clozapine-treated islets. Clozapine, a muscarinic blocker, acutely inhibited carbachol-induced insulin secretion, as did atropine, whereas after 7 days of culture atropine did not have the inhibitory effect shown by clozapine after 7 days. The impairment of glucose-stimulated insulin secretion recovered 3 days after the removal of clozapine treatment. CONCLUSIONS/
INTERPRETATION: The present study demonstrated that the atypical antipsychotic drug clozapine directly impaired insulin secretion via multiple sites including glucose metabolism and the distal step in insulin exocytosis in a long-term culture condition. These mechanisms may be involved in the form of diabetes mellitus associated with atypical antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072584     DOI: 10.1007/s00125-006-0446-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

1.  Noncompetitive inhibition by camphor of nicotinic acetylcholine receptors.

Authors:  T J Park; H K Seo; B J Kang; K T Kim
Journal:  Biochem Pharmacol       Date:  2001-04-01       Impact factor: 5.858

Review 2.  Schizophrenia.

Authors:  Robert Freedman
Journal:  N Engl J Med       Date:  2003-10-30       Impact factor: 91.245

3.  Diabetic ketoacidosis associated with clozapine treatment.

Authors:  M S Koval; L J Rames; S Christie
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

4.  Letter: Clozapine and agranulocytosis.

Authors:  J Idänpään-Heikkilä; E Alhava; M Olkinuora; I Palva
Journal:  Lancet       Date:  1975-09-27       Impact factor: 79.321

5.  Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.

Authors:  Marilyn Ader; Stella P Kim; Karyn J Catalano; Viorica Ionut; Katrin Hucking; Joyce M Richey; Morvarid Kabir; Richard N Bergman
Journal:  Diabetes       Date:  2005-03       Impact factor: 9.461

6.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

7.  Glucose intolerance with atypical antipsychotics.

Authors:  Karin Hedenmalm; Staffan Hägg; Malin Ståhl; Orjan Mortimer; Olav Spigset
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.

Authors:  C Nordin; B Almé; U Bondesson
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

9.  Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance.

Authors:  G Schaber; I Stevens; H J Gaertner; K Dietz; U Breyer-Pfaff
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 10.  Schizophrenia, the metabolic syndrome and diabetes.

Authors:  R I G Holt; R C Peveler; C D Byrne
Journal:  Diabet Med       Date:  2004-06       Impact factor: 4.359

View more
  10 in total

Review 1.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.

Authors:  R R Girgis; J A Javitch; J A Lieberman
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

Review 2.  Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.

Authors:  Katrina Weston-Green; Xu-Feng Huang; Chao Deng
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

Review 3.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

Review 4.  Atypical antipsychotic-induced weight gain: insights into mechanisms of action.

Authors:  James L Roerig; Kristine J Steffen; James E Mitchell
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

Review 5.  [Psychotropic drugs and diabetes].

Authors:  Claudia Ress; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2011-07-29

6.  Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Allyson Cole-Strauss; Jack W Lipton
Journal:  Schizophr Res       Date:  2011-04-07       Impact factor: 4.939

Review 7.  Pancreatic Islet Responses to Metabolic Trauma.

Authors:  Susan J Burke; Michael D Karlstad; J Jason Collier
Journal:  Shock       Date:  2016-09       Impact factor: 3.454

8.  Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling.

Authors:  Ting Cao; Qian Chen; BiKui Zhang; XiangXin Wu; CuiRong Zeng; ShuangYang Zhang; HuaLin Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-14       Impact factor: 5.555

9.  Transcriptional Regulation of the Mitochondrial Citrate and Carnitine/Acylcarnitine Transporters: Two Genes Involved in Fatty Acid Biosynthesis and β-oxidation.

Authors:  Vito Iacobazzi; Vittoria Infantino; Ferdinando Palmieri
Journal:  Biology (Basel)       Date:  2013-01-29

Review 10.  Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain.

Authors:  Diana Grajales; Vitor Ferreira; Ángela M Valverde
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.